Pascal and Francis Bibliographic Databases


Search results

Your search

kw.\*:("Minimal residual disease")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV


A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1245

  • Page / 50


Selection :

  • and

Potentials for RNAi in sarcoma research and therapy: Ewing's sarcoma as a modelKOVAR, Heinrich; BAN, Josef; POSPISILOVA, Sarka et al.Seminars in cancer biology. 2003, Vol 13, Num 4, pp 275-281, issn 1044-579X, 7 p.Article

Reply to: What do we mean by sensitivity when we talk about detecting minimal residual disease? by Steinbach et alROSS, D. M; BRANFORD, S; MELO, J. V et al.Leukemia. 2009, Vol 23, Num 4, pp 819-820, issn 0887-6924, 2 p.Article

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNetØSTERGAARD, M; NYVOLD, C. G; SCHNITTGER, S et al.Leukemia. 2011, Vol 25, Num 7, pp 1168-1173, issn 0887-6924, 6 p.Article

PRAME mRNA levels in cases with acute leukemia : Clinical importance and future prospectsPAYDAS, Semra; TANRIVERDI, Kahraman; YAVUZ, Sinan et al.American journal of hematology. 2005, Vol 79, Num 4, pp 257-261, issn 0361-8609, 5 p.Article

Understanding the progression of melanocytic neoplasia using genomic analysis: from fields to cancerBASTIAN, Boris C.Oncogene (Basingstoke). 2003, Vol 22, Num 20, pp 3081-3086, issn 0950-9232, 6 p.Article

Minimal residual disease (MRD) in follicular lymphoma in the era of immunotherapy with rituximabHIRT, Carsten; SCHÜLER, Frank; DOLKEN, Gottfried et al.Seminars in cancer biology. 2003, Vol 13, Num 3, pp 223-231, issn 1044-579X, 9 p.Article

PCR detection of clonal IgH and TCR gene rearrangements at the end of induction as a non-remission criterion in children with ALL: Comparison with standard morphologic analysis and risk group classificationSCRIDELI, Carlos Alberto; GOMES DE PAULA QUEIROZ, Rosane; BERNARDES, José Eduardo et al.Medical and pediatric oncology. 2003, Vol 41, Num 1, pp 10-16, issn 0098-1532, 7 p.Article

Enhanced sensitivity of flow cytometry for routine assessment of minimal residual diseaseDOMINGO, Esther; MORENO, Cristina; SANCHEZ-IBARROLA, Alfonso et al.Haematologica (Roma). 2010, Vol 95, Num 4, pp 691-692, issn 0390-6078, 2 p.Article

Recent advances in the detection of bone marrow micrometastases : A promising area for research or just another false hope? A review of the literature : Bone metastasis and cancerATHANASSIADOU, Pauline; GRAPSA, Dimitra.Cancer metastasis reviews. 2006, Vol 25, Num 4, pp 507-519, issn 0167-7659, 13 p.Article

Monitoring of minimal residual disease in acute myeloid leukemia : Acute leukemiasKERN, Wolfgang; SCHOCH, Claudia; HAFERLACH, Torsten et al.Critical reviews in oncology/hematology. 2005, Vol 56, Num 2, pp 283-309, issn 1040-8428, 27 p.Article

The expression of PRAME in chronic lymphoproliferative disordersPROTO-SIQUEIRA, Rodrigo; PASSETTO FALCAO, Roberto; DE SOUZA, Carmino Antonio et al.Leukemia research. 2003, Vol 27, Num 5, pp 393-396, issn 0145-2126, 4 p.Article

Molecular markers in acute myeloid leukaemia : PIH: How to improve the outcome of adult acute myeloid leukemia?KÜHNL, Andrea; GRIMWADE, David.International journal of hematology. 2012, Vol 96, Num 2, pp 153-163, issn 0925-5710, 11 p.Article

The Role of Multiparameter Flow Cytometry for Detection of Minimal Residual Disease in Acute Myeloid LeukemiaAL-MAWALI, Adhra; GILLIS, David; LEWIS, Ian et al.American journal of clinical pathology. 2009, Vol 131, Num 1, pp 16-26, issn 0002-9173, 11 p.Article

Oncogenic microRNAs as biomarkers of oral tumorigenesis and minimal residual diseaseSANTHI, W. S; PRATHIBHA, R; CHARLES, Sona et al.Oral oncology (1997). 2013, Vol 49, Num 6, pp 567-575, issn 1368-8375, 9 p.Article

Identification of complement C3f-desArg and its derivative for acute leukemia diagnosis and minimal residual disease assessmentTINGTING LIANG; NA WANG; ZHONGHUA DU et al.Proteomics (Weinheim. Print). 2010, Vol 10, Num 1, pp 90-98, issn 1615-9853, 9 p.Article

Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple MyelomaGUPTA, Ritu; BHASKAR, Archana; KUMAR, Lalit et al.American journal of clinical pathology. 2009, Vol 132, Num 5, pp 728-732, issn 0002-9173, 5 p.Article

Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual diseaseOOSTERLING, S. J; VAN DER BIJ, G. J; BÖGELS, M et al.Cancer immunology and immunotherapy. 2006, Vol 55, Num 9, pp 1043-1051, issn 0340-7004, 9 p.Article

Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapyOKCU, M. Fatih; ROBERTS, W. Mark; JOHNSTON, Dennis A et al.Leukemia research. 2003, Vol 27, Num 8, pp 743-750, issn 0145-2126, 8 p.Article

Minimal residual disease in neuroblastoma: To GAGE or not to GAGEOLTRA, S; MARTINEZ, F; ORELLANA, C et al.Oncology research. 2004, Vol 14, Num 6, pp 291-295, issn 0965-0407, 5 p.Article

MHC-class I antigen expression on micrometastases in bone marrow of patients with head and neck squamous cell cancerANDRATSCHKE, M; PAULI, C; STEIN, M et al.Anticancer research. 2003, Vol 23, Num 2B, pp 1467-1471, issn 0250-7005, 5 p.Article

Minimal residual disease in chronic lymphocytic leukaemia : is it ready for primetime?NABHAN, Chadi; COUTRE, Steven; HILLMEN, Peter et al.British journal of haematology. 2007, Vol 136, Num 3, pp 379-392, issn 0007-1048, 14 p.Article

Prognostic impact of early response to induction therapy as assessed by multiparameter flow cytometry in acute myeloid leukemiaKERN, Wolfgang; VOSKOVA, Daniela; SCHOCH, Claudia et al.Haematologica (Roma). 2004, Vol 89, Num 5, pp 528-540, issn 0390-6078, 13 p.Article

Minimal Residual Disease Investigation in Haematological MalignanciesFORONI, Letizia; HOFFBRAND, Victor.Baillière's best practice & research. Clinical haematology. 2002, Vol 15, Num 1, issn 1521-6926, 233 p.Serial Issue

Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionGAIPA, G; BASSO, G; COLIVA, T et al.Leukemia. 2005, Vol 19, Num 1, pp 49-56, issn 0887-6924, 8 p.Article

Wilms' tumour gene 1 (WT1) in human neoplasiaKEILHOLZ, U; MENSSEN, H. D; GAIGER, A et al.Leukemia. 2005, Vol 19, Num 8, pp 1318-1323, issn 0887-6924, 6 p.Article

  • Page / 50